ACLX - Arcellx jumps after data for Gilead-partnered multiple myeloma drug
2023-11-02 12:44:44 ET
More on Arcellx, Gilead, etc.
- Gilead Sciences Stock Is Cheap, With Broad Pipeline
- Gilead Sciences: Does The Stocks Reward Outweigh The Risk
- Gilead Sciences: A Healthy Buy With Solid Dividend
- Eli Lilly, Gilead favorites at BofA ahead of Q3 biopharma earnings
- Gilead and Assembly Bio ink deal for antiviral drugs
For further details see:
Arcellx jumps after data for Gilead-partnered multiple myeloma drug